Management of Acute Respiratory Distress Syndrome and Refractory Hypoxemia. A Multicenter Observational Study.

Abstract

RATIONALE:

Clinicians' current practice patterns in the management of acute respiratory distress syndrome (ARDS) and refractory hypoxemia are not well described.

OBJECTIVES:

To describe mechanical ventilation strategies and treatment adjuncts for adults with ARDS, including refractory hypoxemia.

METHODS:

This was a prospective cohort study (March 2014-February 2015) of mechanically ventilated adults with moderate-to-severe ARDS requiring an FiO2 of 0.50 or greater in 24 intensive care units.

RESULTS:

We enrolled 664 patients: 222 (33%) with moderate and 442 (67%) with severe ARDS. On Study Day 1, mean Vt was 7.5 (SD = 2.1) ml/kg predicted body weight (n = 625); 80% (n = 501) received Vt greater than 6 ml/kg. Mean positive end-expiratory pressure (PEEP) was 10.5 (3.7) cm H2O (n = 653); 568 patients (87%) received PEEP less than 15 cm H2O. Treatment adjuncts were common (n = 440, 66%): neuromuscular blockers (n = 276, 42%), pulmonary vasodilators (n = 118, 18%), prone positioning (n = 67, 10%), extracorporeal life support (n = 29, 4%), and high-frequency oscillatory ventilation (n = 29, 4%). Refractory hypoxemia, defined as PaO2 less than 60 mm Hg on FiO2 of 1.0, occurred in 138 (21%) patients. At onset of refractory hypoxemia, mean Vt was 7.1 (SD = 2.0) ml/kg (n = 124); 95 patients (77%) received Vt greater than 6 ml/kg. Mean PEEP was 12.1 (SD = 4.4) cm H2O (n = 133); 99 patients (74%) received PEEP less than 15 cm H2O. Among patients with refractory hypoxemia, 91% received treatment adjuncts (126/138), with increased use of neuromuscular blockers (n = 87, 63%), pulmonary vasodilators (n = 57, 41%), and prone positioning (n = 32, 23%).

CONCLUSIONS:

Patients with moderate-to-severe ARDS receive treatment adjuncts frequently, especially with refractory hypoxemia. Paradoxically, therapies with less evidence supporting their use (e.g., pulmonary vasodilators) were over-used, whereas those with more evidence (e.g., prone positioning, neuromuscular blockade) were under-used. Patients received higher Vts and lower PEEP than would be suggested by the evidence.

• Authors: Erick H Duan, Neill K J Adhikari, Frederick D'Aragon, Deborah J Cook, Sangeeta Mehta, Waleed Alhazzani, Ewan Goligher, Emmanuel Charbonney, Yaseen M Arabi, Tim Karachi, Alexis F Turgeon, Lori Hand, Qi Zhou, Peggy Austin, Jan Friedrich, Francois Lamontagne, François Lauzier, Rakesh Patel, John Muscedere, Richard Hall, Pierre Aslanian, Thomas Piraino, Martin Albert, Sean M Bagshaw, Mike Jacka, Gordon Wood, William Henderson, Delbert Dorscheid, Niall D Ferguson, Maureen O Meade, Canadian Critical Care Trials Group
• Journal: Annals of the American Thoracic Society (Ann Am Thorac Soc) Vol. 14 Issue 12 Pg. 1818-1826 (Dec 2017) ISSN: 2325-6621 [Electronic] United States
• PMID: 28910146 (Publication Type: Journal Article, Multicenter Study, Observational Study)

Chemical References

• Neuromuscular Blocking Agents

Topics

• Adult
• Aged
• Blood Gas Analysis
• Canada
• Disease Management
• Extracorporeal Membrane Oxygenation
• Female
• High-Frequency Ventilation
• Humans
• Hypoxia (therapy)
• Intensive Care Units (organization & administration)
• Logistic Models
• Lung (physiopathology)
• Male
• Middle Aged
• Multivariate Analysis
• Neuromuscular Blocking Agents (therapeutic use)
• Positive-Pressure Respiration
• Prone Position
• Prospective Studies
• Respiratory Distress Syndrome (therapy)
• Risk Factors
• Severity of Illness Index
• Tidal Volume